Trials / Completed
CompletedNCT00232115
Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
An evaluation of the safety and efficacy of the calcineurin inhibitor, pimecrolimus cream 1%, in adult patients with perioral dermatitis. This study is not enrolling patients in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pimecrolimus | Pimecrolimus cream 1 % |
| DRUG | Placebo | Vehicle cream (placebo) |
Timeline
- Start date
- 2005-09-01
- Completion
- 2006-07-01
- First posted
- 2005-10-04
- Last updated
- 2008-01-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00232115. Inclusion in this directory is not an endorsement.